Efficacy and Safety of TransCon PTH in Adults With Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial - Top-Institutions - MDSpire

Efficacy and Safety of TransCon PTH in Adults With Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial

  • By

  • Bart L Clarke

  • Aliya A Khan

  • Mishaela R Rubin

  • Peter Schwarz

  • Tamara Vokes

  • Dolores M Shoback

  • Claudia Gagnon

  • Andrea Palermo

  • Lisa G Abbott

  • Lorenz C Hofbauer

  • Lynn Kohlmeier

  • Filomena Cetani

  • Susanne Pihl

  • Xuebei An

  • Alden R Smith

  • Bryant Lai

  • Jenny Ukena

  • Christopher T Sibley

  • Aimee D Shu

  • Lars Rejnmark

  • October 8, 2024

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Endocrinology
    • Metabolic Bone Disease
    • Clinical Research

  • #2

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Endocrinology
    • Clinical Trials
    • Bone and Mineral Metabolism

  • #3

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Endocrinology
    • Metabolic Bone Disease
    • Clinical Research

  • #4

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Endocrinology
    • Bone and Mineral Metabolism
    • Clinical Trials

Original Source(s)

Efficacy and Safety of TransCon PTH in Adults With Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial

  • by Bart L Clarke, Aliya A Khan, Mishaela R Rubin, Peter Schwarz, Tamara Vokes, Dolores M Shoback, Claudia Gagnon, Andrea Palermo, Lisa G Abbott, Lorenz C Hofbauer, Lynn Kohlmeier, Filomena Cetani, Susanne Pihl, Xuebei An, Alden R Smith, Bryant Lai, Jenny Ukena, Christopher T Sibley, Aimee D Shu, Lars Rejnmark

  • October 8, 2024

Related Content

Ultrasound Models Estimate Whole-Body Muscle Mass

New equations incorporating cross-sectional area improve estimation accuracy.

Assessing the Predictive Utility of L1 Cortical Bone CT Parameters for Osteoporosis Risk

Comparison of Efficacy of Romosozumab With Denosumab and Risedronate in Patients Newly Initiating Glucocorticoid Therapy